The clinical value of CA19-9 and CEA in diagnosing pancreas cancer

Objective To investigate the clinical value of the tumor marker CA19-9 and carcinoembryonic antigen(CEA) in human serum in diagnosis of pancreas cancer.Methods The concentrations of CA19-9 and CEA in serum in thirty-two patients with pancreas cancer and thirty-two patients with benign pancreatic disease were detected with Elecsys 1010 auto electrochemiluminescene immune analyzer.Results The levels of CA19-9 and CEA in the former group were (106.3±79.1)ng/ml and (7.2±0.7)ng/ml ,which were significantly higher than those in the latter group.Conculsion The value of CA19-9 in diagnosing of pancreas cancer is higher than that of CEA .But the combined detection of CA19-9 and CEA is clinically significant to diagnosis of pancreas cancer .